Morgan Molloy

Morgan brings to Atalanta more than 25 years of operational and commercial leadership experience in the biopharmaceutical industry, with specific expertise in business strategy and organizational growth. He most recently served as Chief Corporate Development Officer at Akouos. Prior to Akouos, Morgan was Chief Commercial Officer at Enzyvant where he led all aspects of the commercial strategy for the company’s rare disease portfolio. Earlier in his career he held leadership roles at Spark Therapeutics, Genzyme, and Biogen. Morgan holds a B.S. in business management with concentrations in finance and marketing from the University of Massachusetts, Lowell.